These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27140413)

  • 1. Novel immunotherapies for the treatment of melanoma.
    Gato-Cañas M; Arasanz H; Blanco-Luquin I; Glaría E; Arteta-Sanchez V; Kochan G; Escors D
    Immunotherapy; 2016 May; 8(5):613-32. PubMed ID: 27140413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
    Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
    Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for melanoma.
    Cuevas LM; Daud AI
    Semin Cutan Med Surg; 2018 Jun; 37(2):127-131. PubMed ID: 30040090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the immune system for the treatment of melanoma: current status and future prospects.
    Guennoun A; Sidahmed H; Maccalli C; Seliger B; Marincola FM; Bedognetti D
    Expert Rev Clin Immunol; 2016 Aug; 12(8):879-93. PubMed ID: 27070898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for advanced melanoma: Current knowledge and future directions.
    Nakamura K; Okuyama R
    J Dermatol Sci; 2016 Aug; 83(2):87-94. PubMed ID: 27302423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for the management of advanced melanoma: the next steps.
    Zikich D; Schachter J; Besser MJ
    Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling and Immune Regulation in Melanoma Development and Responses to Therapy.
    Lin WM; Fisher DE
    Annu Rev Pathol; 2017 Jan; 12():75-102. PubMed ID: 27959628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].
    Moura B; Homicsko K; Berthod G; Cerottini JP; Guggisberg D; Gaide O; Maillard MH; Michielin O
    Rev Med Suisse; 2015 May; 11(475):1108, 1110-4. PubMed ID: 26152085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of tumor-infiltrating lymphocyte efficacy in melanoma.
    Zikich D; Schachter J; Besser MJ
    Immunotherapy; 2016; 8(1):35-43. PubMed ID: 26653685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapies in Combination With Immune Therapies for the Treatment of Metastatic Melanoma.
    Christiansen SA; Khan S; Gibney GT
    Cancer J; 2017; 23(1):59-62. PubMed ID: 28114256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of melanoma].
    Dréno B
    Bull Acad Natl Med; 2010 Oct; 194(7):1373-81. PubMed ID: 22043632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition.
    Lau PK; Ascierto PA; McArthur G
    Curr Opin Immunol; 2016 Apr; 39():30-8. PubMed ID: 26765776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic melanoma and immunotherapy.
    Herzberg B; Fisher DE
    Clin Immunol; 2016 Nov; 172():105-110. PubMed ID: 27430520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation of immunotherapy for melanoma.
    Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
    J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of melanoma: efficacy and mode of action.
    Wieder T; Brenner E; Braumüller H; Röcken M
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):28-37. PubMed ID: 26713633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A malignus melanoma immunterápiájának lehetoségei].
    Ladányi A
    Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interface of signal transduction inhibition and immunotherapy in melanoma.
    Shada AL; Molhoek KR; Slingluff CL
    Cancer J; 2010; 16(4):360-6. PubMed ID: 20693848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of Melanoma.
    Bender C; Hassel JC; Enk A
    Oncol Res Treat; 2016; 39(6):369-76. PubMed ID: 27259558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of melanoma: present options and future promises.
    Rotte A; Bhandaru M; Zhou Y; McElwee KJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma: the new perspectives from clinical and translational research.
    Occelli M; Vandone AM; Cauchi C; Merlano MC
    Anticancer Drugs; 2019 Jul; 30(6):543-553. PubMed ID: 31021826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.